Novel antitumor 2-cyanoaziridine-1-carboxamides

Journal of Medicinal Chemistry

Volumn 42, Issue 3, 1999, Pages 510-514

  Iyengar, Bhashyam S ^a   Dorr, Robert T ^b   Alberts, David S ^b   Hersh, Evan M ^b   Salmon, Sydney E ^b   Remers, William A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANOAZIRIDINE 1 CARBOXAMIDE; ANTINEOPLASTIC AGENT; IMEXON; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SOLID TUMOR; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; AZIRIDINES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032972043     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980600x     Document Type: Article

References (33)

1. Dermer, O. C.; Ham, G. E. Ethyleneimine and Other Aziridines; Academic Press: New York and London, 1969; pp 425-441.
2. Goodridge, T. H.; Huntress, W. T.; Bratzell, R. P. Survey of Aziridines. Cancer Chemother. Rep. 1963, 26, 341-443.
3. Reynolds, R. C. Aziridines. In Cancer Chemotherapeutic Agents; Foye, W. O., Ed.; American Chemical Society: Washington, DC, 1995; pp 186-197.
4. Dorr, R. T.; Von Hoff, D. D. Cancer Chemotherapy Handbook, 2nd ed.; Appleton and Lange: Norwalk, CT, 1994; pp 375-380.
5. Remers, W. A.; Iyengar, B. S. Antitumor Antibiotics. In Cancer Chemotherapeutic Agents; Foye, W. O., Ed.; American Chemical Society: Washington, DC, 1995; pp 584-592.
6. Bicker, U. W. Immunopharmacological Properties of 2-Cyanaziridine Derivatives. In Immune Modulation Agents and Their Mechanisms; Fenical, R. G., Chirigos, M. A., Eds.; Marcel Dekker: New York and Basle, 1984; pp 447-473.
7. Bicker, U. N-(2-Cyanoethylene)urea - an Asparagine Analogous Cytostatic Compound? Exp. Pathol. 1975, 10, 106-108.
8. Bicker, U.; Fichse, P. Carcinostatic Action of 2-Cyanoaziridines Against Sarcoma in Rats. Exp. Pathol. 1975, 10, 279-284.
9. Schaumann, W.; Determann, H.; Bicker, U.; Rothe, W.; Lettenbauer, G.; Kampe, W. Use of 2-Cyanoaziridine and Its Derivatives for Immunostimulation. Ger. Offen. 2, 736, 296, Feb 22, 1979.
10. Bicker, U.; Kampe, W.; Steingross, W. U.S. Patent 4,083,987, Apr 11, 1978.
11. Bicker, U.; Hebold, G. Cancerostatic Action of the Immune-Stimulating Compound 4-imino-1,3-diazabicyclo[3.1.0]hexane-2-one, BM 06 002 (Proposed INN Name Imexon) on Various Transplantation Tumors. IRCS Med. Sci.: Cancer; Hematol. Immunol. Allergy; Pharmacol. 1977, 5, 428.
12. Hersh, E. M.; Dorr, R. T.; Curtis, R. A.; Prince, J. E. Antitumor Effects of Imexon Combined with Myelosuppressive and Non Myelosuppressive Anticancer Agents. Proc. Am. Assoc. Cancer Res. 1995, 36, 294.
13. Micksche, M.; Kokoschka, E. M.; Sagaster, P.; Bicker, U. Phase I Study for a new Immunostimulant Drug, BM 06 002, in Man. In Immune Modulation and Control of Neoplasia by Adjuvant Therapy; Chirigos, M. M., Ed.; Raven Press: New York, 1978; pp 403-413.
14. Sagaster, P.; Kokoschka, E. M.; Kokron, O.; Micksche, M. Antitumor Activity of Imexon. J. Natl. Cancer Inst. 1995, 87, 935-936.
15. Hersh, E. M.; Gschwind, C. R.; Taylor, C. W.; Dorr, R. T.; Taetle, R.; Salmon, S. E. Antiproliferative and Antitumor Activity of the 2-Cyanoaziridine Compound Imexon on Tumor Cell Lines and Fresh Tumor Cells In Vitro. J. Natl. Cancer Inst. 1992, 84. 1238-1244.
16. Berger, H.; Gall, R.; Kampe, W.; Bicker, U.; Hebold, G. German Pat. 2,644,820, Apr 6, 1978.
17. Berger, H.; Gall, R.; Kampe, W.; Bicker, U. German Pat. 2,727,550, Jan 4, 1979.
18. Boises, E.; Heerdt, R.; Gall, R.; Bicker, U.; Ziegler, A. E. German Pat. 2,740,248, Mar 15, 1979.
19. Boises, E.; Heerdt, R.; Gall, R.; Bicker, U.; Ziegler, A. E. German Pat. 2,656,323, June 15, 1979.
20. Jähnisch, J.; Weigt, E.; Bosies, E. Chemie von Aziridinecarbonsäuren; 2. Mitteilung Eine Einfach Synthese von 2-Aminopropennitril. (Chemistry of Aziridinecarboxylic Acids; 2. Note on a Simple Synthesis of 2-Aminopropenenitrile.) Synthesis 1992, 1211-1212.
21. Hyden, S.; Wilbert, G. Chem. Ind. (London) 1967, 3, 1406-1407.
22. Matsuoka, Y.; Moore, G. E.; Yagi, Y.; Pressman, D. Production of Free Light Chains of Immunoglobulin by a Hematopoetic Cell Line Derived from a Patient with Multiple Myeloma. Proc. Soc. Exp. Biol. Med. 1967, 125, 1246-1250.
23. Hamilton, T. C.; Young, R. C.; Ozols, R. F. Experimental Model systems of Ovarian Cancer: Applications to the Design and Evaluation of New Treatment Approaches. Semin. Oncol. 1984, 11, 285-298.
24. Girard, D. J.; Aaronson, S. A.; Todaro, G. J.; Arnstein, P.; Kersey, J. H.; Dosik, H.; Parks, W. P. In vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived from a Series of Solid Tumors. J. Natl. Cancer Inst. 1973, 51, 1417-1423.
25. Taylor, C. W.; Dalton, W. S.; Parrish, P. R.; Gleason, M. C.; Bellamy, W. T.; Thompson, F. H.; Roe, D. J.; Trent, J. M. Different Mechanisms of Decreased Drug Accumulation in Doxorubicin and Mitoxantrone Resistant Variants of the MCF7 Human Breast Cancer Cell Line. Br. J. Cancer 1991, 63, 923-929.
26. Futscher, B. W.; Abbaszadegan, M. R.; Domann, F.; Dalton, W. S. Analysis of MRP mRNA in Mitoxantrone-Selected, Multidurg-Resistant Human Tumor Cells. Biochem. Pharmacol. 1994, 47, 1601-1606.
27. Noguchi, P.; Wallace, R.; Jonson, J.; Barley, E. M.; O'Brien, S.; Ferrone, S.; Pellegrino, M. A.; Milstein, J.; Needy, C.; Browne, W.; Petricciani, J. Characterization of WiDr: a Human Colon Carcinoma Cell Line. In Vitro 1979, 35, 401-407.
28. Dalton, W. S.; Cress, A. E.; Alberts, D. S.; Trent, J. M. Cytogenetic and Phenotypic Analysis of a Human Colon Carcinoma Cell Line Resistant to Mitoxantrone. Cancer Res. 1988, 48, 1882-1888.
29. Goldin, A.; Venditti, J. M.; Kline, I.; Mantel, N. Evaluation of Antileukemic Agents Employing Advanced Leukemia L1210 in Mice. IV. (Various Compounds). Cancer Res. 1961, 21, 27-92.
30. Dorr, R. T.; Kiddil, J. D.; Trent, J. M.; Dalton, W. S. Mitomycin C Resistant L1210 Leukemia Cells: Association with Plieotropic Drug Resistance. Biochem. Pharmacol. 1987, 36, 3115-3120.
31. Sigmastat 1.0 for Windows is available from Jandel Scientific, 2591 Kerner Blvd, San Rafael, CA 94912-8920.
32. Salmon, S. E.; Liu, R.; Casazza, A. M. Evaluation of New Anthracycline Analogues with the Human Tumor Stem Cell Assay. Cancer Chemother. Pharmacol. 1981, 6, 103-109.
33. Salmon, S. E.; Hersh, E. M. Sensitivity of Multiple Myeloma to Imexon in the Human Tumor Cloning Assay. J. Natl. Cancer Inst. 1994, 86, 228-230.